WESTLAKE VILLAGE, Calif., Dec. 8, 2003 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFV), manufacturer, distributor and marketers of biomedical diagnostics and NICOWate(tm), a Homeopathic Nicotinum Formula, today announced it will be providing up to 10,000 HIV 1 & 2 tests for investigational evaluation by potential Governmental and Institutional customers. Although the test is currently in Phase III ease of use in the United States, the company has already received investigational sample requests from vendors supplying China, Taiwan and a number of European Government Agencies.
"Once we announced the dramatic potential and superior benefits of our new products, we experienced an overwhelming rate of inquiries," according to QT 5, Inc. CEO Timothy J. Owens. "This overwhelming interest confirms our company's belief in the viability and potential impact of our patented Target System Diagnostics Platform. The Ten-minute HIV 1 & 2 Test certainly addresses one of the most timely and widespread diagnostic demands in Biomedical market today. Perhaps the most exciting thing for us is the fact that it still represents only a fraction of the overall long-term potential of our entire line of Diagnostic Products. With 8 other quantifiable and qualitative blood tests and a SAMHSA 5 Urine test already FDA approved, the imminent availability of the HIV 1 & 2 Test signals the first of countless additional products in Development and under consideration."
The Company also announced along with the imminent availability of these samples, they are encouraging all qualified parties that would like to receive evaluation samples, contact them immediately at govtsales@qt5inc.com.
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing and Homeopathic products. QT 5, Inc. currently manufactures and markets NICOWater, its breakthrough Homeopathic Nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings. QT 5 continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: www.qt5inc.com. NICOWater(tm) is a Homeopathic Drug product that is sold under the FDA's Compliance Policy Guide Conditions Under Which Homeopathic Drugs May Be Marketed.
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward looking statements.